https://www.selleckchem.com/products/ms-275.html
4%) vs 156 (14.2%, p0.001), and 125 (16.6%) vs 242 (22.0%, p=0.005), respectively. Multivariable analysis showed that these differences were largely due to confounding features, as after adjustment for baseline, clinical and imaging characteristics no significant difference was found for the above clinical endpoints. Transcatheter mitral valve repair with the MitraClip in carefully selected octogenarians appears feasible and safe, and is associated with favorable clinical outcomes at mid-term follow-up. Transcatheter mitral valve rep
Beğen
Yorum Yap
Paylaş
